Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women. [electronic resource]
Producer: 20010802Description: 801-7 p. digitalISSN:- 1058-4838
- AIDS Vaccines -- administration & dosage
- Adjuvants, Immunologic -- administration & dosage
- Female
- HIV Envelope Protein gp120 -- genetics
- HIV Infections -- prevention & control
- Humans
- Infant, Newborn
- Infectious Disease Transmission, Vertical -- prevention & control
- Polysorbates -- administration & dosage
- Pregnancy
- Pregnancy Complications, Infectious
- Squalene -- administration & dosage
- Vaccination
- Vaccines, Synthetic -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.